Prognostic significance of copy number alterations detected by multi-link probe amplification of multiple genes in adult acute lymphoblastic leukemia

The multiplex ligation-dependent probe amplification (MLPA) method was used to detect the copy number alterations (CNAs) of IKAROS family zinc finger 1 (IKZF1), paired box 5 (PAX5), ETS variant 6 (ETV6), RB transcriptional corepressor 1 (RB1), BTG anti-proliferation factor 1 (BTG1), early B-cell fac...

Full description

Saved in:
Bibliographic Details
Published inOncology letters Vol. 15; no. 4; pp. 5359 - 5367
Main Authors Fang, Qiuyun, Yuan, Tian, Li, Yan, Feng, Juan, Gong, Xiaoyuan, Li, Qinghua, Zhao, Xingli, Liu, Kaiqi, Tang, Kejing, Tian, Zheng, Zhang, Qi, Wang, Ying, Liu, Bingcheng, Wang, Min, Ru, Kun, Wang, Jianxiang, Mi, Yingchang
Format Journal Article
LanguageEnglish
Published Greece D.A. Spandidos 01.04.2018
Spandidos Publications
Spandidos Publications UK Ltd
Subjects
Online AccessGet full text
ISSN1792-1074
1792-1082
1792-1082
DOI10.3892/ol.2018.7985

Cover

Abstract The multiplex ligation-dependent probe amplification (MLPA) method was used to detect the copy number alterations (CNAs) of IKAROS family zinc finger 1 (IKZF1), paired box 5 (PAX5), ETS variant 6 (ETV6), RB transcriptional corepressor 1 (RB1), BTG anti-proliferation factor 1 (BTG1), early B-cell factor 1 (EBF1), cyclin dependent kinase inhibitor 2A/2B (CDKN2A/2B) and cytokine receptor like factor 2 (CRLF2) genes in 87 adults with acute lymphoblastic leukemia (ALL) in China. The effects of CNAs on prognosis were analyzed. Gene deletions were detected in 58/87 (66.7%) ALL patients. The most common deletions were observed in the following genes: IKZF1 (40.6%), CDKN2A (31.9%), CDKN2B (29%), PAX5 (21.7%), RB1 (14.5%) and BTG1 (10.1%). B cell-ALL (B-ALL) patients with CDKN2A/2B deletions exhibited poor 2-year overall survival (OS; P=0.055) and relapse-free survival (RFS; P=0.054) rates. CDKN2A/2B deletions were associated with poor 2-year OS (P=0.045) and RFS (P=0.071) rates in Philadelphia chromosome positive (Ph+) B-ALL patients, as well as in the high risk (HR) B-ALL group (P=0.037 and P=0.047, respectively). Patients with PAX5 deletions displayed poor 2-year OS (P=0.004) and RFS (P=0.016) rates in Philadelphia chromosome negative (Ph−) B-ALL patients. Patients with ≥3 gene deletions exhibited a poorer prognosis than other patients (OS, P=0.001; RFS, 0.002).
AbstractList The multiplex ligation-dependent probe amplification (MLPA) method was used to detect the copy number alterations (CNAs) of IKAROS family zinc finger 1 (IKZF1), paired box 5 (PAX5), ETS variant 6 (ETV6), RB transcriptional corepressor 1 (RB1), BTG anti-proliferation factor 1 (BTG1), early B-cell factor 1 (EBF1), cyclin dependent kinase inhibitor 2A/2B (CDKN2A/2B) and cytokine receptor like factor 2 (CRLF2) genes in 87 adults with acute lymphoblastic leukemia (ALL) in China. The effects of CNAs on prognosis were analyzed. Gene deletions were detected in 58/87 (66.7%) ALL patients. The most common deletions were observed in the following genes: IKZF1 (40.6%), CDKN2A (31.9%), CDKN2B (29%), PAX5 (21.7%), RB1 (14.5%) and BTG1 (10.1%). B cell-ALL (B-ALL) patients with CDKN2A/2B deletions exhibited poor 2-year overall survival (OS; P=0.055) and relapse-free survival (RFS; P=0.054) rates. CDKN2A/2B deletions were associated with poor 2-year OS (P=0.045) and RFS (P=0.071) rates in Philadelphia chromosome positive (Ph+) B-ALL patients, as well as in the high risk (HR) B-ALL group (P=0.037 and P=0.047, respectively). Patients with PAX5 deletions displayed poor 2-year OS (P=0.004) and RFS (P=0.016) rates in Philadelphia chromosome negative (Ph−) B-ALL patients. Patients with ≥3 gene deletions exhibited a poorer prognosis than other patients (OS, P=0.001; RFS, 0.002).
The multiplex ligation-dependent probe amplification (MLPA) method was used to detect the copy number alterations (CNAs) of IKAROS family zinc finger 1 (IKZF1), paired box 5 (PAX5), ETS variant 6 (ETV6), RB transcriptional corepressor 1 (RBI), BTG anti-proliferation factor 1 (BTG1), early B-cell factor 1 (EBF1), cyclin dependent kinase inhibitor 2A/2B (CDKN2A/2B) and cytokine receptor like factor 2 (CRLF2) genes in 87 adults with acute lymphoblastic leukemia (ALL) in China. The effects of CNAs on prognosis were analyzed. Gene deletions were detected in 58/87 (66.7%) ALL patients. The most common deletions were observed in the following genes: IKZF1 (40.6%), CDKN2A (31.9%), CDKN2B (29%), PAX5 (21.7%), RBI (14.5%) and BTG1 (10.1%). B cell-ALL (B-ALL) patients with CDKN2A/2B deletions exhibited poor 2-year overall survival (OS; P=0.055) and relapse-free survival (RFS; P=0.054) rates. CDKN2A/2B deletions were associated with poor 2-year OS (P=0.045) and RFS (P=0.071) rates in Philadelphia chromosome positive ([Ph.sup.+]) B-ALL patients, as well as in the high risk (HR) B-ALL group (P=0.037 and P=0.047, respectively). Patients with PAX5 deletions displayed poor 2-year OS (P=0.004) and RFS (P=0.016) rates in Philadelphia chromosome negative (Ph) B-ALL patients. Patients with [greater than or equal to]3 gene deletions exhibited a poorer prognosis than other patients (OS, P=0.001; RFS, 0.002). Key words: adult, acute lymphoblastic leukemia, multiplex ligation-dependent probe amplification, copy number alterations, prognosis
The multiplex ligation-dependent probe amplification (MLPA) method was used to detect the copy number alterations (CNAs) of IKAROS family zinc finger 1 ( ), paired box 5 ( ), ETS variant 6 ( ), RB transcriptional corepressor 1 ( ), BTG anti-proliferation factor 1 ( ), early B-cell factor 1 ( ), cyclin dependent kinase inhibitor 2A/2B ( ) and cytokine receptor like factor 2 ( ) genes in 87 adults with acute lymphoblastic leukemia (ALL) in China. The effects of CNAs on prognosis were analyzed. Gene deletions were detected in 58/87 (66.7%) ALL patients. The most common deletions were observed in the following genes: (40.6%), (31.9%), (29%), (21.7%), (14.5%) and (10.1%). B cell-ALL (B-ALL) patients with deletions exhibited poor 2-year overall survival (OS; P=0.055) and relapse-free survival (RFS; P=0.054) rates. deletions were associated with poor 2-year OS (P=0.045) and RFS (P=0.071) rates in Philadelphia chromosome positive (Ph ) B-ALL patients, as well as in the high risk (HR) B-ALL group (P=0.037 and P=0.047, respectively). Patients with deletions displayed poor 2-year OS (P=0.004) and RFS (P=0.016) rates in Philadelphia chromosome negative (Ph ) B-ALL patients. Patients with ≥3 gene deletions exhibited a poorer prognosis than other patients (OS, P=0.001; RFS, 0.002).
The multiplex ligation-dependent probe amplification (MLPA) method was used to detect the copy number alterations (CNAs) of IKAROS family zinc finger 1 (IKZF1), paired box 5 (PAX5), ETS variant 6 (ETV6), RB transcriptional corepressor 1 (RB1), BTG anti-proliferation factor 1 (BTG1), early B-cell factor 1 (EBF1), cyclin dependent kinase inhibitor 2A/2B (CDKN2A/2B) and cytokine receptor like factor 2 (CRLF2) genes in 87 adults with acute lymphoblastic leukemia (ALL) in China. The effects of CNAs on prognosis were analyzed. Gene deletions were detected in 58/87 (66.7%) ALL patients. The most common deletions were observed in the following genes: IKZF1 (40.6%), CDKN2A (31.9%), CDKN2B (29%), PAX5 (21.7%), RB1 (14.5%) and BTG1 (10.1%). B cell-ALL (B-ALL) patients with CDKN2A/2B deletions exhibited poor 2-year overall survival (OS; P=0.055) and relapse-free survival (RFS; P=0.054) rates. CDKN2A/2B deletions were associated with poor 2-year OS (P=0.045) and RFS (P=0.071) rates in Philadelphia chromosome positive (Ph+) B-ALL patients, as well as in the high risk (HR) B-ALL group (P=0.037 and P=0.047, respectively). Patients with PAX5 deletions displayed poor 2-year OS (P=0.004) and RFS (P=0.016) rates in Philadelphia chromosome negative (Ph-) B-ALL patients. Patients with ≥3 gene deletions exhibited a poorer prognosis than other patients (OS, P=0.001; RFS, 0.002).The multiplex ligation-dependent probe amplification (MLPA) method was used to detect the copy number alterations (CNAs) of IKAROS family zinc finger 1 (IKZF1), paired box 5 (PAX5), ETS variant 6 (ETV6), RB transcriptional corepressor 1 (RB1), BTG anti-proliferation factor 1 (BTG1), early B-cell factor 1 (EBF1), cyclin dependent kinase inhibitor 2A/2B (CDKN2A/2B) and cytokine receptor like factor 2 (CRLF2) genes in 87 adults with acute lymphoblastic leukemia (ALL) in China. The effects of CNAs on prognosis were analyzed. Gene deletions were detected in 58/87 (66.7%) ALL patients. The most common deletions were observed in the following genes: IKZF1 (40.6%), CDKN2A (31.9%), CDKN2B (29%), PAX5 (21.7%), RB1 (14.5%) and BTG1 (10.1%). B cell-ALL (B-ALL) patients with CDKN2A/2B deletions exhibited poor 2-year overall survival (OS; P=0.055) and relapse-free survival (RFS; P=0.054) rates. CDKN2A/2B deletions were associated with poor 2-year OS (P=0.045) and RFS (P=0.071) rates in Philadelphia chromosome positive (Ph+) B-ALL patients, as well as in the high risk (HR) B-ALL group (P=0.037 and P=0.047, respectively). Patients with PAX5 deletions displayed poor 2-year OS (P=0.004) and RFS (P=0.016) rates in Philadelphia chromosome negative (Ph-) B-ALL patients. Patients with ≥3 gene deletions exhibited a poorer prognosis than other patients (OS, P=0.001; RFS, 0.002).
The multiplex ligation-dependent probe amplification (MLPA) method was used to detect the copy number alterations (CNAs) of IKAROS family zinc finger 1 (IKZF1), paired box 5 (PAX5), ETS variant 6 (ETV6), RB transcriptional corepressor 1 (RBI), BTG anti-proliferation factor 1 (BTG1), early B-cell factor 1 (EBF1), cyclin dependent kinase inhibitor 2A/2B (CDKN2A/2B) and cytokine receptor like factor 2 (CRLF2) genes in 87 adults with acute lymphoblastic leukemia (ALL) in China. The effects of CNAs on prognosis were analyzed. Gene deletions were detected in 58/87 (66.7%) ALL patients. The most common deletions were observed in the following genes: IKZF1 (40.6%), CDKN2A (31.9%), CDKN2B (29%), PAX5 (21.7%), RBI (14.5%) and BTG1 (10.1%). B cell-ALL (B-ALL) patients with CDKN2A/2B deletions exhibited poor 2-year overall survival (OS; P=0.055) and relapse-free survival (RFS; P=0.054) rates. CDKN2A/2B deletions were associated with poor 2-year OS (P=0.045) and RFS (P=0.071) rates in Philadelphia chromosome positive ([Ph.sup.+]) B-ALL patients, as well as in the high risk (HR) B-ALL group (P=0.037 and P=0.047, respectively). Patients with PAX5 deletions displayed poor 2-year OS (P=0.004) and RFS (P=0.016) rates in Philadelphia chromosome negative (Ph) B-ALL patients. Patients with [greater than or equal to]3 gene deletions exhibited a poorer prognosis than other patients (OS, P=0.001; RFS, 0.002).
Audience Academic
Author Mi, Yingchang
Zhang, Qi
Li, Qinghua
Wang, Ying
Zhao, Xingli
Tang, Kejing
Ru, Kun
Yuan, Tian
Tian, Zheng
Gong, Xiaoyuan
Li, Yan
Feng, Juan
Wang, Jianxiang
Fang, Qiuyun
Liu, Bingcheng
Liu, Kaiqi
Wang, Min
AuthorAffiliation 3 Hematology Department, Tianjin Cancer Hospital, Tianjin 300060, P.R. China
1 Leukemia Department, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China
2 Hematological Cancer Laboratory, State Key Laboratory of Experimental Hematology, Tianjin 300020, P.R. China
AuthorAffiliation_xml – name: 1 Leukemia Department, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China
– name: 3 Hematology Department, Tianjin Cancer Hospital, Tianjin 300060, P.R. China
– name: 2 Hematological Cancer Laboratory, State Key Laboratory of Experimental Hematology, Tianjin 300020, P.R. China
Author_xml – sequence: 1
  givenname: Qiuyun
  surname: Fang
  fullname: Fang, Qiuyun
  organization: 1Leukemia Department, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China
– sequence: 2
  givenname: Tian
  surname: Yuan
  fullname: Yuan, Tian
  organization: 3Hematology Department, Tianjin Cancer Hospital, Tianjin 300060, P.R. China
– sequence: 3
  givenname: Yan
  surname: Li
  fullname: Li, Yan
  organization: 1Leukemia Department, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China
– sequence: 4
  givenname: Juan
  surname: Feng
  fullname: Feng, Juan
  organization: 1Leukemia Department, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China
– sequence: 5
  givenname: Xiaoyuan
  surname: Gong
  fullname: Gong, Xiaoyuan
  organization: 1Leukemia Department, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China
– sequence: 6
  givenname: Qinghua
  surname: Li
  fullname: Li, Qinghua
  organization: 1Leukemia Department, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China
– sequence: 7
  givenname: Xingli
  surname: Zhao
  fullname: Zhao, Xingli
  organization: 1Leukemia Department, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China
– sequence: 8
  givenname: Kaiqi
  surname: Liu
  fullname: Liu, Kaiqi
  organization: 1Leukemia Department, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China
– sequence: 9
  givenname: Kejing
  surname: Tang
  fullname: Tang, Kejing
  organization: 1Leukemia Department, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China
– sequence: 10
  givenname: Zheng
  surname: Tian
  fullname: Tian, Zheng
  organization: 1Leukemia Department, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China
– sequence: 11
  givenname: Qi
  surname: Zhang
  fullname: Zhang, Qi
  organization: 1Leukemia Department, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China
– sequence: 12
  givenname: Ying
  surname: Wang
  fullname: Wang, Ying
  organization: 1Leukemia Department, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China
– sequence: 13
  givenname: Bingcheng
  surname: Liu
  fullname: Liu, Bingcheng
  organization: 1Leukemia Department, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China
– sequence: 14
  givenname: Min
  surname: Wang
  fullname: Wang, Min
  organization: 1Leukemia Department, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China
– sequence: 15
  givenname: Kun
  surname: Ru
  fullname: Ru, Kun
  organization: 1Leukemia Department, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China
– sequence: 16
  givenname: Jianxiang
  surname: Wang
  fullname: Wang, Jianxiang
  organization: 1Leukemia Department, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China
– sequence: 17
  givenname: Yingchang
  surname: Mi
  fullname: Mi, Yingchang
  organization: 1Leukemia Department, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29552179$$D View this record in MEDLINE/PubMed
BookMark eNqFkk1v1DAQhiNUREvpjTOyBEIcyOI4cWJfKlUVX9JK5QBny7EnWbeOHeIEtD-E_4uTLdtuBcI-2Bo_8471zjxNjpx3kCTPM7zKGSfvvF0RnLFVxRl9lJxkFSdphhk52t-r4jg5C-Eax0XLjLHySXJMOKUkAifJry-Db50Po1EomNaZxijpFCDfIOX7LXJTV8OApB1hkKPxLiANI6gRNKq3qJvsaFJr3A3qB18Dkl1vF5GZnVUWoreAWnAQkHFI6hhCUk0jILvt-o2vrVx-YGG6gc7IZ8njRtoAZ7fnafLtw_uvl5_S9dXHz5cX61TRnI8pLSrJi7xWhcJa5irnWVNzTUqgdU5pLrUkTGsJuK650kVTFiVWpSYFz1UDJD9N0p3u5Hq5_SmtFf1gOjlsRYbF7LDwVswOi9nhyJ_v-H6qO9AK3DjIuxwvjTh8cWYjWv9DUFbgks0F39wKDP77BGEUnQkKrJUO_BTmUrTIKK-qiL58gF77aXDRjkgRHClWkTuqlRaEcY2PddUsKi5oTnGOGcORWv2FiltHt1UcqcbE-EHC63sJG4jt3wRvp2UADsEX9x3ZW_FnwiJAdoAafAgDNEKZcRmO-AVj_-Xz2wdJ_2nLqx0eeum00T7s-at1iuNesN9KdAGN
CitedBy_id crossref_primary_10_3389_fonc_2022_981036
crossref_primary_10_1080_07853890_2024_2427365
crossref_primary_10_1515_biol_2022_0652
crossref_primary_10_1038_s41409_024_02306_2
crossref_primary_10_1007_s00277_024_06102_2
crossref_primary_10_1038_s41598_021_88449_4
crossref_primary_10_3389_fonc_2021_677034
Cites_doi 10.1182/blood-2014-03-562918
10.1038/leu.2013.92
10.1002/gcc.20818
10.1093/nar/gnf056
10.1080/10428194.2016.1180682
10.1002/cncr.29579
10.1158/1078-0432.CCR-11-1227
10.1038/nature05690
10.1182/blood-2009-08-239681
10.1038/nrclinonc.2015.38
10.1002/pbc.24571
10.1038/leu.2012.155
10.1038/sj.leu.2404691
10.1053/j.seminhematol.2008.09.003
ContentType Journal Article
Copyright Copyright © 2018, Spandidos Publications
COPYRIGHT 2018 Spandidos Publications
Copyright Spandidos Publications UK Ltd. 2018
Copyright © 2018, Spandidos Publications 2018
Copyright_xml – notice: Copyright © 2018, Spandidos Publications
– notice: COPYRIGHT 2018 Spandidos Publications
– notice: Copyright Spandidos Publications UK Ltd. 2018
– notice: Copyright © 2018, Spandidos Publications 2018
DBID HUR
AAYXX
CITATION
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AN0
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ADTOC
UNPAY
DOI 10.3892/ol.2018.7985
DatabaseName Spandidos Publications Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest Central
British Nursing Database
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
PubMed
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
British Nursing Index with Full Text
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
ProQuest One Health & Nursing
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central (New)
ProQuest One Academic
ProQuest Central (Alumni)
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList


PubMed
MEDLINE - Academic

ProQuest One Academic Middle East (New)

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
– sequence: 3
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1792-1082
EndPage 5367
ExternalDocumentID 10.3892/ol.2018.7985
PMC5840682
A535030880
29552179
10_3892_ol_2018_7985
OL-0-0-7985
Genre Journal Article
GeographicLocations United States--US
China
Germany
GeographicLocations_xml – name: China
– name: United States--US
– name: Germany
GroupedDBID ---
0R~
53G
7X7
8FI
8FJ
AAKDD
ABDBF
ABJNI
ABUWG
ACGFS
ACUHS
ADBBV
AENEX
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AN0
BENPR
BNQBC
BPHCQ
BVXVI
C45
CCPQU
EBD
EBS
EJD
ESX
F5P
FYUFA
H13
HMCUK
HUR
HZ~
IAO
IHR
IHW
IPNFZ
ITC
O9-
OK1
OVD
PHGZM
PHGZT
PPXIY
PQQKQ
PROAC
PUEGO
RIG
RPM
TEORI
UKHRP
W2D
AAYXX
CITATION
ALIPV
NPM
3V.
7XB
8FK
K9.
PJZUB
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c539t-547a943bc4c0da3c391fb9d26e5b3553ada28ddae0bb9cd4f6460c6d2493cfe23
IEDL.DBID UNPAY
ISSN 1792-1074
1792-1082
IngestDate Sun Oct 26 03:59:08 EDT 2025
Tue Sep 30 15:46:15 EDT 2025
Fri Sep 05 11:04:21 EDT 2025
Tue Oct 07 07:03:14 EDT 2025
Mon Oct 20 21:58:08 EDT 2025
Mon Oct 20 16:23:40 EDT 2025
Thu May 22 21:21:05 EDT 2025
Mon Jul 21 06:04:39 EDT 2025
Thu Apr 24 22:52:11 EDT 2025
Wed Oct 01 02:40:56 EDT 2025
Tue Sep 30 17:19:12 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 4
Keywords adult
acute lymphoblastic leukemia
prognosis
copy number alterations
multiplex ligation-dependent probe amplification
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c539t-547a943bc4c0da3c391fb9d26e5b3553ada28ddae0bb9cd4f6460c6d2493cfe23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://proxy.k.utb.cz/login?url=http://www.spandidos-publications.com/10.3892/ol.2018.7985/download
PMID 29552179
PQID 2020415872
PQPubID 2044954
PageCount 9
ParticipantIDs unpaywall_primary_10_3892_ol_2018_7985
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5840682
proquest_miscellaneous_2015415977
proquest_journals_2020415872
gale_infotracmisc_A535030880
gale_infotracacademiconefile_A535030880
gale_healthsolutions_A535030880
pubmed_primary_29552179
crossref_citationtrail_10_3892_ol_2018_7985
crossref_primary_10_3892_ol_2018_7985
spandidos_primary_OL-0-0-7985
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-04-01
PublicationDateYYYYMMDD 2018-04-01
PublicationDate_xml – month: 04
  year: 2018
  text: 2018-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Greece
PublicationPlace_xml – name: Greece
– name: Athens
PublicationTitle Oncology letters
PublicationTitleAlternate Oncol Lett
PublicationYear 2018
Publisher D.A. Spandidos
Spandidos Publications
Spandidos Publications UK Ltd
Publisher_xml – name: D.A. Spandidos
– name: Spandidos Publications
– name: Spandidos Publications UK Ltd
References Schouten, McElgunn, Waaijer, Zwijnenburg, Diepvens, Pals (b6-ol-0-0-7985) 2002; 30
Yamashita, Shimada, Yamada, Yamaji, Hori, Tsurusawa, Watanabe, Kikuta, Asami, Saito, Horibe (b14-ol-0-0-7985) 2013; 60
Zhao, Wie, Lin, Wang, Zhou, Liu, Li, Liu, Wang, Li (b7-ol-0-0-7985) 2014; 35
Kuiper, Schoenmakers, van Reijmersdal, Hehir-Kwa, van Kessel, van Leeuwen, Hoogerbrugge (b2-ol-0-0-7985) 2007; 21
Schwab, Jones, Morrison, Ryan, Yigittop, Schouten, Harrison (b5-ol-0-0-7985) 2010; 49
Gökbuget, Hoelzer (b9-ol-0-0-7985) 2009; 46
Moorman, Enshaei, Schwab, Wade, Chilton, Elliott, Richardson, Hancock, Kinsey, Mitchell (b11-ol-0-0-7985) 2014; 124
Ribera, Morgades, Zamora, Montesinos, Gómez-Seguí, Pratcorona, Sarrà, Guàrdia, Nomdedeu, Tormo (b15-ol-0-0-7985) 2015; 121
Mullighan, Goorha, Radtke, Miller, Coustan-Smith, Dalton, Girtman, Mathew, Ma, Pounds (b1-ol-0-0-7985) 2007; 446
Harvey, Mullighan, Wang, Dobbin, Davidson, Bedrick, Chen, Atlas, Kang, Ar (b3-ol-0-0-7985) 2010; 116
Krentz, Hof, Mendioroz, Vaggopoulou, Dörge, Lottaz, Engelmann, Groeneveld, Körner, Seeger (b12-ol-0-0-7985) 2013; 27
Ofverholm, Tran, Heyman, Zachariadis, Nordenskjöld, Nordgren, Barbany (b10-ol-0-0-7985) 2013; 27
Iacobucci, Ferrari, Lonetti, Papayannidis, Paoloni, Trino, Storlazzi, Ottaviani, Cattina, Impera (b16-ol-0-0-7985) 2011; 17
Yuan, Zhao, Zhang, Li, Tian, Tang, Wang, Lin, Li, Liu (b13-ol-0-0-7985) 2013; 21
Roberts, Mullighan (b4-ol-0-0-7985) 2015; 12
Fang, Zhao, Li, Li, Liu, Tang, Wang, Liu, Wang, Xing (b8-ol-0-0-7985) 2017; 58
Zhao (key20200714003122_b7-ol-0-0-7985) 2014; 35
Fang (key20200714003122_b8-ol-0-0-7985) 2017; 58
Gökbuget (key20200714003122_b9-ol-0-0-7985) 2009; 46
Iacobucci (key20200714003122_b16-ol-0-0-7985) 2011; 17
Ofverholm (key20200714003122_b10-ol-0-0-7985) 2013; 27
Yuan (key20200714003122_b13-ol-0-0-7985) 2013; 21
Mullighan (key20200714003122_b1-ol-0-0-7985) 2007; 446
Schouten (key20200714003122_b6-ol-0-0-7985) 2002; 30
Schwab (key20200714003122_b5-ol-0-0-7985) 2010; 49
Krentz (key20200714003122_b12-ol-0-0-7985) 2013; 27
Ribera (key20200714003122_b15-ol-0-0-7985) 2015; 121
Kuiper (key20200714003122_b2-ol-0-0-7985) 2007; 21
Roberts (key20200714003122_b4-ol-0-0-7985) 2015; 12
Moorman (key20200714003122_b11-ol-0-0-7985) 2014; 124
Yamashita (key20200714003122_b14-ol-0-0-7985) 2013; 60
Harvey (key20200714003122_b3-ol-0-0-7985) 2010; 116
References_xml – volume: 124
  start-page: 1434
  year: 2014
  end-page: 1444
  ident: b11-ol-0-0-7985
  article-title: A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia
  publication-title: Blood
  doi: 10.1182/blood-2014-03-562918
– volume: 27
  start-page: 1936
  year: 2013
  end-page: 1939
  ident: b10-ol-0-0-7985
  article-title: Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols
  publication-title: Leukemia
  doi: 10.1038/leu.2013.92
– volume: 35
  start-page: 873
  year: 2014
  end-page: 879
  ident: b7-ol-0-0-7985
  article-title: Optimal treatment of adult Ph negative acute lymphoblastic leukemia
  publication-title: Zhonghua Xue Ye Xue Za Zhi
– volume: 49
  start-page: 1104
  year: 2010
  end-page: 1113
  ident: b5-ol-0-0-7985
  article-title: Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia
  publication-title: Genes Chromosomes Cancer
  doi: 10.1002/gcc.20818
– volume: 30
  start-page: e57
  year: 2002
  ident: b6-ol-0-0-7985
  article-title: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gnf056
– volume: 58
  start-page: 127
  year: 2017
  end-page: 137
  ident: b8-ol-0-0-7985
  article-title: IKZF1 alterations and expressions of CRLF2 predict prognosis in Chinese adult patients with B-cell precursor acute lymphoblastic leukemia
  publication-title: Leuk Lymphoma
  doi: 10.1080/10428194.2016.1180682
– volume: 121
  start-page: 3809
  year: 2015
  end-page: 3817
  ident: b15-ol-0-0-7985
  article-title: Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols
  publication-title: Cancer
  doi: 10.1002/cncr.29579
– volume: 17
  start-page: 7413
  year: 2011
  end-page: 7423
  ident: b16-ol-0-0-7985
  article-title: CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-11-1227
– volume: 446
  start-page: 758
  year: 2007
  end-page: 764
  ident: b1-ol-0-0-7985
  article-title: Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
  publication-title: Nature
  doi: 10.1038/nature05690
– volume: 116
  start-page: 4874
  year: 2010
  end-page: 4884
  ident: b3-ol-0-0-7985
  article-title: Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: Correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome
  publication-title: Blood
  doi: 10.1182/blood-2009-08-239681
– volume: 12
  start-page: 344
  year: 2015
  end-page: 357
  ident: b4-ol-0-0-7985
  article-title: Genomics in acute lymphoblastic leukaemia: Insights and treatment implications
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/nrclinonc.2015.38
– volume: 60
  start-page: 1587
  year: 2013
  end-page: 1592
  ident: b14-ol-0-0-7985
  article-title: IKZF1 and CRLF2 gene alterations correlate with poor prognosis in Japanese BCR-ABL1-negative high-risk B-cell precursor acute lymphoblastic leukemia
  publication-title: Pediatr Blood Cancer
  doi: 10.1002/pbc.24571
– volume: 27
  start-page: 295
  year: 2013
  end-page: 304
  ident: b12-ol-0-0-7985
  article-title: Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia
  publication-title: Leukemia
  doi: 10.1038/leu.2012.155
– volume: 21
  start-page: 539
  year: 2013
  end-page: 543
  ident: b13-ol-0-0-7985
  article-title: Expression and clinical significance of IKZF1 gene IK6 isoforms in adult acute lymphoblastic leukemia
  publication-title: Zhongguo Shi Yan Xue Ye Xue Za Zhi
– volume: 21
  start-page: 1258
  year: 2007
  end-page: 1266
  ident: b2-ol-0-0-7985
  article-title: High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2404691
– volume: 46
  start-page: 64
  year: 2009
  end-page: 75
  ident: b9-ol-0-0-7985
  article-title: Treatment of adult acute lymphoblastic leukemia
  publication-title: Semin Hematol
  doi: 10.1053/j.seminhematol.2008.09.003
– volume: 446
  start-page: 758
  year: 2007
  ident: key20200714003122_b1-ol-0-0-7985
  article-title: Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
  publication-title: Nature
  doi: 10.1038/nature05690
– volume: 124
  start-page: 1434
  year: 2014
  ident: key20200714003122_b11-ol-0-0-7985
  article-title: A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia
  publication-title: Blood
  doi: 10.1182/blood-2014-03-562918
– volume: 49
  start-page: 1104
  year: 2010
  ident: key20200714003122_b5-ol-0-0-7985
  article-title: Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia
  publication-title: Genes Chromosomes Cancer
  doi: 10.1002/gcc.20818
– volume: 30
  start-page: e57
  year: 2002
  ident: key20200714003122_b6-ol-0-0-7985
  article-title: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gnf056
– volume: 27
  start-page: 1936
  year: 2013
  ident: key20200714003122_b10-ol-0-0-7985
  article-title: Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols
  publication-title: Leukemia
  doi: 10.1038/leu.2013.92
– volume: 17
  start-page: 7413
  year: 2011
  ident: key20200714003122_b16-ol-0-0-7985
  article-title: CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-11-1227
– volume: 12
  start-page: 344
  year: 2015
  ident: key20200714003122_b4-ol-0-0-7985
  article-title: Genomics in acute lymphoblastic leukaemia: Insights and treatment implications
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/nrclinonc.2015.38
– volume: 60
  start-page: 1587
  year: 2013
  ident: key20200714003122_b14-ol-0-0-7985
  article-title: IKZF1 and CRLF2 gene alterations correlate with poor prognosis in Japanese BCR-ABL1-negative high-risk B-cell precursor acute lymphoblastic leukemia
  publication-title: Pediatr Blood Cancer
  doi: 10.1002/pbc.24571
– volume: 116
  start-page: 4874
  year: 2010
  ident: key20200714003122_b3-ol-0-0-7985
  article-title: Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: Correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome
  publication-title: Blood
  doi: 10.1182/blood-2009-08-239681
– volume: 35
  start-page: 873
  year: 2014
  ident: key20200714003122_b7-ol-0-0-7985
  article-title: Optimal treatment of adult Ph negative acute lymphoblastic leukemia
  publication-title: Zhonghua Xue Ye Xue Za Zhi
– volume: 121
  start-page: 3809
  year: 2015
  ident: key20200714003122_b15-ol-0-0-7985
  article-title: Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols
  publication-title: Cancer
  doi: 10.1002/cncr.29579
– volume: 46
  start-page: 64
  year: 2009
  ident: key20200714003122_b9-ol-0-0-7985
  article-title: Treatment of adult acute lymphoblastic leukemia
  publication-title: Semin Hematol
  doi: 10.1053/j.seminhematol.2008.09.003
– volume: 58
  start-page: 127
  year: 2017
  ident: key20200714003122_b8-ol-0-0-7985
  article-title: IKZF1 alterations and expressions of CRLF2 predict prognosis in Chinese adult patients with B-cell precursor acute lymphoblastic leukemia
  publication-title: Leuk Lymphoma
  doi: 10.1080/10428194.2016.1180682
– volume: 27
  start-page: 295
  year: 2013
  ident: key20200714003122_b12-ol-0-0-7985
  article-title: Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia
  publication-title: Leukemia
  doi: 10.1038/leu.2012.155
– volume: 21
  start-page: 539
  year: 2013
  ident: key20200714003122_b13-ol-0-0-7985
  article-title: Expression and clinical significance of IKZF1 gene IK6 isoforms in adult acute lymphoblastic leukemia
  publication-title: Zhongguo Shi Yan Xue Ye Xue Za Zhi
– volume: 21
  start-page: 1258
  year: 2007
  ident: key20200714003122_b2-ol-0-0-7985
  article-title: High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2404691
SSID ssj0000561886
Score 2.2169876
Snippet The multiplex ligation-dependent probe amplification (MLPA) method was used to detect the copy number alterations (CNAs) of IKAROS family zinc finger 1...
The multiplex ligation-dependent probe amplification (MLPA) method was used to detect the copy number alterations (CNAs) of IKAROS family zinc finger 1 ( ),...
SourceID unpaywall
pubmedcentral
proquest
gale
pubmed
crossref
spandidos
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 5359
SubjectTerms acute lymphoblastic leukemia
Acute lymphocytic leukemia
adult
Adults
Age
Analysis
Blood
Blood diseases
Care and treatment
Chemotherapy
Chromosomes
copy number alterations
Copy number variations
Cytokines
Deoxyribonucleic acid
Development and progression
DNA
Genes
Genetic aspects
Health aspects
Hematology
Investigations
Leukemia
Medical prognosis
multiplex ligation-dependent probe amplification
Oncology
Pediatrics
Prognosis
Transcription factors
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Zb9QwELbKVgJeEDeBFozE8YAM2cRJ7AeECmpVIbpUiEp9i3zCihAv7a7Q_hD-LzO52FSiykskT05_Hs94Ps8Q8kyD6--MKpiKuWfcFJ7Jwltm1TTTwiupY9zgfDTLD0_4x9PsdIvM-r0wSKvsdWKjqG0wuEaOTjruJhdF8m7xi2HVKIyu9iU0VFdawb5tUoxdIdsJZsaakO33-7PjL8OqC9rLoin_CEBMGLIRWzY8zNvJm4CxiKl4XUgsrbwxT13U1hvT1UUq5TVQBLWd23AO56t6oda_VVVtzFkHN8mNztikey06bpEtV98mV4-6cPod8uf4LCDRDpopEjmQNoQooMFTExZr2tYLoU1IvV3ao9Zh2MFZqte0YSMyjAFTLEzjqEJ-uu-WAfEuPV-RfkOdSuc1bRJ-UGVWS0erNWApaDDg8Q0qt_rhfs7VXXJysP_1wyHr6jQwk6VyyTJeKMlTbbiJrUpNKqdeS5vkLtNgzqTKqkRYq1ystTSW-5znsckteH6p8S5J75FJHWr3gFDjleMAn0RqAY6qFZmXQmmhc3CdHDcRedX3Smm6JOZYS6MqwZnBPixDVWIfltiHEXk-SC_a5B3_kXuCHVy2W0-HMV_uZWmG-XxEHJGXjQSOenieUd3mBXhrzJ81ktwZScJoNePmHkRlpy3Oy3_YjsjToRmvRAZc7cIKZcDYnWK2wIjcbzE3fFMiM7DCChmRYoTGQQBziI9b6vn3Jpc42J9xLuC5uwNuh6s-f2IxHO0fejFg-dJf-fDy73tErqNoS33aIZPl2crtglW31I-7ofoXIURPUw
  priority: 102
  providerName: ProQuest
Title Prognostic significance of copy number alterations detected by multi-link probe amplification of multiple genes in adult acute lymphoblastic leukemia
URI https://www.ncbi.nlm.nih.gov/pubmed/29552179
https://www.proquest.com/docview/2020415872
https://www.proquest.com/docview/2015415977
https://pubmed.ncbi.nlm.nih.gov/PMC5840682
http://www.spandidos-publications.com/10.3892/ol.2018.7985/download
UnpaywallVersion publishedVersion
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1792-1082
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000561886
  issn: 1792-1074
  databaseCode: ABDBF
  dateStart: 20130801
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1792-1082
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000561886
  issn: 1792-1074
  databaseCode: RPM
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1792-1082
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000561886
  issn: 1792-1074
  databaseCode: 7X7
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Proquest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1792-1082
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000561886
  issn: 1792-1074
  databaseCode: BENPR
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB61iQRceD8MbVgkHofKqePn7jGgVhWiIUJEKidrnxDV2FEbC4UTf4ET_49fwo7tmLgVCAnlstKOvevJeHbG-823AE-FTf215InLvdC4oUyMyxKjXMVHkaCGM-FhgfPxJD6aha9PopMtWJ_SiahK-yblaq6Kc3ex8eWq8tqYY1Lm7xe4aTCiw4TRaF8hq3zB1Tb048gG5D3ozybT8YeqFJL5LkIOf7epX8PfL92nszBddM8b69NF7OTVdr62XeYLvvrCs2xjkTq8AWpd6lNjU06H5VIM5dfLzI__8_w34XoTxJJxbXW3YEvnt-HKcbNNfwd-TM8KBPDZboIAEYQjoXWRwhBZLFakPoeEVFv19cBEadzO0IqIFalQjj-_fcfdZYJH3mjCEflummnifdZISPIRvTWZ56SiEiFclktNspW10kLY1ADnkOnyVH-e87swOzx4_-rIbU6AcGUUsKUbhQlnYSBkKD3FAxmwkRFM-bGOhA2UAq64T5Xi2hOCSRWaOIw9GSubUwbSaD-4B728yPUDINJwHVrD9JmgNgVWNDKMckFFbJMyHUoH9tZ_fyobenQ8pSNLbZqESk-LLEWlp6h0B5610ouaFuQPco_RktK6qLX1Juk4CiJkCqKeAy8qCfQndjzJm7IIO2tk5upI7nQkrR-Q3e61taaNHzq3E_GRg4EmvgNP2m68ErF1uS5KlLFh9Ah5CB24Xxt3-0w-i2x8lzAHko7ZtwLITt7tyeefKpZyG9l6MbXj7rYG3V719o3r2V-toeftS_NXVT78V8FHcA3bNbxqB3rLs1Lv2shxKQawnZwkA-i_PJhM3w0aP_ELvqtz4Q
linkProvider Unpaywall
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF5VrUS5IN4YWrpIFA5oi2Ov7d1DhQq0amkSKtRKvZl9GSKMHZpEVX4If4ffxoxfJJXorcrF0o7jx4znsfPNDCEvNYT-zqiEKZ9njJskYzLJLLOqF2mRKal9LHAeDOPDM_7pPDpfIX_aWhiEVbY6sVLUtjS4R45BOlaTiyR4N_7FcGoUZlfbERqqGa1gd6sWY01hx7GbX0IIN9k9-gj83g6Cg_3TD4esmTLATBTKKYt4oiQPteHGtyo0oexlWtogdpEGYxwqqwJhrXK-1tJYnsU89k1sIW4JTeaw8QGYgDUecgnB39r7_eHJl26XB_1zUY2bBMEPGKIfa_Q9-AnB2xJzHz2xk0gc5bxgF69ahwXzeBW6uQ6Kp7AjW07geFaM1fxS5fmCjTy4S-40zi3dq6XxHllxxX1ya9Ck7x-Q3ycXJQL7YJkicARhSih1tMyoKcdzWs8noVUKv95KpNZhmsNZque0Qj8yzDlTHITjqEI8fNZsO-K_tPhI-g11OB0VtGowQpWZTR3N5yC7pYaAAe8gd7Mf7udIPSRnN8KxR2S1KAv3hFCTKcdBXAOpBQTGVkSZFEoLHUOo5rjxyJuWK6lpmqbj7I48heAJeZiWeYo8TJGHHtnuqMd1s5D_0G0hg9O61LXTMeleFEbYP0j4HnldUaCWgesZ1RRLwF1jv64lyo0lStAOZnm5FaK00U6T9N-35JEX3TKeiYi7wpUzpAHnuofdCT3yuJa57pkCGYHXl0iPJEvS2BFgz_LllWL0vepdDv6uHwu47mYnt91Zn_vMh1_9hl51snztq3x6_fNtkfXD00E_7R8Nj5-R23haDbvaIKvTi5nbBI9yqp83ny0lX29aU_wFqfaN4w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF5VRSpcEG8MLV0kCge01PFrdw8IVZSopQ96oFJv7j4hwtihSVTlh_Bn-HXM-EVSid6qXCztOH7M59mZnW9nCHmlIfR3RnGmwsSzxHDPJPeWWTVItfBK6hA3OB8dZ3unyeez9GyF_On2wiCtsrOJtaG2lcE1cgzScTe54NG2b2kRJ7vDD-NfDDtIYaa1a6fRQOTAzS8hfJu8398FXW9F0fDT1497rO0wwEwayylLE65kEmuTmNCq2MRy4LW0UeZSDRNxrKyKhLXKhVpLYxOfJVloMgsxS2y8w6IHYP5v8TiWSCfkZ7xf30HPXNSNJgHyEUPeY8O7Bw8h2q4w6zEQ77jEJs4LM-LVeWFhYrxK2rwNJqe0I1tN4HhWjtX8UhXFwuw4vEfutm4t3WlweJ-suPIBWTtqE_cPye-TiwopfTBMkTKCBCXEG608NdV4TpvOJLRO3jeLiNQ6THA4S_Wc1rxHhtlmii1wHFXIhPftgiP-S8eMpN_QetNRSevSIlSZ2dTRYg6orTSECngHhZv9cD9H6hE5vRF9PSarZVW6p4Qar1wCQI2kFhASW5F6KZQWOoMgzSUmIG87reSmLZeOXTuKHMIm1GFeFTnqMEcdBmSrlx43ZUL-I7eJCs6bTa69dcl30jjFykEiDMibWgLtC1zPqHabBNw1VupaklxfkgS7YJaHOxDlrV2a5P--ooC87IfxTOTala6aoQy41QOsSxiQJw3m-meKZAr-HpcB4Uto7AWwWvnySDn6XlctB083zARcd6PHbX_Wl0MWwq95Q697LF_7Kp9d_3ybZA3sQ364f3zwnNzBsxq-1TpZnV7M3Aa4klP9ov5mKTm_aSPxF9Tqi30
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELbKVoJeeFMCLRiJxwFlm03ixD6uEFWFaOmBlcop8hNWDcmqTYSWE3-BE_-PX8JMkg2bViAktBdLnsTO7GQ8E3_zmZCnClJ_q2XqyyB2fqxT54vUGd_ICVPcSaECLHA-PEoOZvGbE3ayQVandCKqEt6kwsxNee4v1r5cNV4bc0wuwr0SNw0mfJwKzvYMssqX0lwhmwmDgHxENmdHx9MPTSmkCH2EHP5u87CFv1-6z2Bhuuie19ani9jJa_18oV0XC7n8IvN8bZHav0HMqtSnxaacjutKjfXXy8yP__P8N8n1Loil09bqbpENW9wmVw-7bfo75MfxWYkAPuimCBBBOBJaFy0d1eViSdtzSGizVd8OTI3F7QxrqFrSBuX489t33F2meOSNpRKR766bJt5nhYSkH9Fb03lBGyoRKnVdWZovwUpLBakBziG39an9PJd3yWz_9ftXB353AoSvWSQqn8WpFHGkdKwDIyMdiYlTwoSJZQoCpUgaGXJjpA2UEtrELomTQCcGcspIOxtG98ioKAt7n1DtpI3BMEOhOKTAhjMnuFRcJZCU2Vh75OXq7890R4-Op3TkGaRJqPSszDNUeoZK98izXnrR0oL8Qe4xWlLWFrX23iSbsoghUxAPPPKikUB_AuNp2ZVFwKyRmWsguTOQBD-gh90ra806P3QOEwmRg4GnoUee9N14JWLrClvWKANh9AR5CD2y3Rp3_0yhYBDfpcIj6cDsewFkJx_2FPNPDUs5RLZBwmHc3d6g-6vevfUD-LUaet6_NH9V5YN_FXxItrDdwqt2yKg6q-0uRI6VetR5hl9_3XFg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prognostic+significance+of+copy+number+alterations+detected+by+multi-link+probe+amplification+of+multiple+genes+in+adult+acute+lymphoblastic+leukemia&rft.jtitle=Oncology+letters&rft.au=Fang%2C+Qiuyun&rft.au=Yuan%2C+Tian&rft.au=Li%2C+Yan&rft.au=Feng%2C+Juan&rft.date=2018-04-01&rft.pub=Spandidos+Publications&rft.issn=1792-1074&rft.volume=15&rft.issue=4&rft.spage=5359&rft_id=info:doi/10.3892%2Fol.2018.7985&rft.externalDocID=A535030880
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1792-1074&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1792-1074&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1792-1074&client=summon